Dr. Maria Millan, President and CEO of the California Institute for Regenerative MedicinePhoto credit: CIRM.

View Large Image | View Hi-Res Image | Download PowerPoint Slide

In late September 2017, the California Institute for Regenerative Medicine (CIRM) appointed Dr. Maria Millan as its new president and CEO. Millan assumes the mantle of leadership at a fraught moment for CIRM. Of the $3 billion in state bond funds used to establish the agency in 2004, about $335 million will remain by the end of the year to support research and clinical development. What’s left will be largely spent by 2020. If CIRM supporters are unable to secure more funding before then, a number of therapies in the agency’s development pipeline might wither on the vine.

中文翻译：

---

Maria Millan博士：移植外科医师领导CIRM运营

加州再生医学研究所所长兼首席执行官Maria Millan博士图片来源：CIRM。

查看大图| 查看高分辨率图像| 下载PowerPoint幻灯片

2017年9月下旬，加利福尼亚再生医学研究所（CIRM）任命Maria Millan博士为新任总裁兼首席执行官。Millan在CIRM的紧要关头担任领导的角色。2004年用于建立该机构的30亿美元国家债券基金中，到年底将剩下约3.35亿美元用于支持研究和临床开发。剩下的钱将在2020年之前花掉。如果CIRM支持者在此之前无法获得更多资金，该机构发展渠道中的许多疗法可能会枯萎。